Dipeptidyl peptidase 4 inhibition may facilitate healing of chronic foot ulcers in patients with type 2 diabetes.
about
The dipeptidyl peptidase-4 inhibitor saxagliptin improves function of circulating pro-angiogenic cells from type 2 diabetic patientsGLP-1 promotes angiogenesis in human endothelial cells in a dose-dependent manner, through the Akt, Src and PKC pathways.Topically applied connective tissue growth factor/CCN2 improves diabetic preclinical cutaneous wound healing: potential role for CTGF in human diabetic foot ulcer healing.Comparative Genome of GK and Wistar Rats Reveals Genetic Basis of Type 2 Diabetes.NRP-1 Receptor Expression Mismatch in Skin of Subjects with Experimental and Diabetic Small Fiber Neuropathy.Diabetes medications: Impact on inflammation and wound healingMicrovascular Outcomes in Patients with Type 2 Diabetes Treated with Vildagliptin vs. Sulfonylurea: A Retrospective Study Using German Electronic Medical Records.NLRP3 Inflammasome Expression and Signaling in Human Diabetic Wounds and in High Glucose Induced Macrophages.Exendin-4 in combination with adipose-derived stem cells promotes angiogenesis and improves diabetic wound healing.Linagliptin: from bench to bedside.DPP4 in cardiometabolic disease: recent insights from the laboratory and clinical trials of DPP4 inhibition.Effectiveness of interventions to enhance healing of chronic ulcers of the foot in diabetes: a systematic review.Involvement of DPP IV/CD26 in cutaneous wound healing process in mice.Accelerated wound healing in mice by on-site production and delivery of CXCL12 by transformed lactic acid bacteria.Coadministration of DPP-4 inhibitor and insulin therapy does not further reduce the risk of cardiovascular events compared with DPP-4 inhibitor therapy in diabetic foot patients: a nationwide population-based study
P2860
Q33662677-054789BE-79E6-47A1-8146-180CD32BA30CQ34727731-94BFAF53-9E9A-458E-8AC7-D3DFC47F8A7AQ35144096-3AE2F3B9-74C6-41E9-92F0-121632A2D329Q35830508-D9F141A3-81F2-4A93-B449-3F069EBB4B38Q36123798-33655CE2-A5E9-451A-8608-0CD5CA87DFBDQ36805643-D877E773-C4BD-489C-9156-144F77F4FBB6Q37239286-5F43AE2D-CC09-4BA4-87DA-ADA625170F77Q37601852-86B413E8-CAD6-4455-9B7E-9EC3163EF015Q37644170-FD4A399E-7A37-408D-B34E-DDC4FB07B5FFQ38213703-F4EB13CD-B957-441A-B798-71BBF69953BAQ38413395-D185A2FA-97F7-42EE-8516-0A3BDB8784C4Q38582159-AEA28AB9-0607-4B3E-8BBD-CCD4625015E7Q39169604-A8952EDF-1321-4747-B8F4-916B3A643F35Q50063686-9A4BA5BC-95B1-42B5-927C-DBBEE3152B0FQ57813255-A4B02842-AA1B-4669-ABB8-6AEC2669A241
P2860
Dipeptidyl peptidase 4 inhibition may facilitate healing of chronic foot ulcers in patients with type 2 diabetes.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Dipeptidyl peptidase 4 inhibit ...... patients with type 2 diabetes.
@ast
Dipeptidyl peptidase 4 inhibit ...... patients with type 2 diabetes.
@en
type
label
Dipeptidyl peptidase 4 inhibit ...... patients with type 2 diabetes.
@ast
Dipeptidyl peptidase 4 inhibit ...... patients with type 2 diabetes.
@en
prefLabel
Dipeptidyl peptidase 4 inhibit ...... patients with type 2 diabetes.
@ast
Dipeptidyl peptidase 4 inhibit ...... patients with type 2 diabetes.
@en
P2093
P2860
P50
P356
P1476
Dipeptidyl peptidase 4 inhibit ...... patients with type 2 diabetes.
@en
P2093
Angela Della Corte
Ferdinando Campitiello
Franca Ferraraccio
Ornella Carbonara
Pasquale Gualdiero
Pasquale Paolisso
Pasquale Petronella
Raffaele Canonico
Raffaele Marfella
Vincenzo Padovano
P2860
P304
P356
10.1155/2012/892706
P50
P577
2012-11-01T00:00:00Z